Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT06432933
Other study ID # 2023-2352
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date April 9, 2024
Est. completion date July 2025

Study information

Verified date May 2024
Source Rijnstate Hospital
Contact Claudia Berends, Msc
Phone +31880055970
Email clberends@rijnstate.nl
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The best perioperative strategy for obstructive sleep apnea (OSA) in bariatric surgery remains unclear. A strategy is to monitor patients and administer preventive oxygen therapy during the first postoperative night. However it is unknown what if preventive oxygen therapy is necessary. The goal of this trial is to compare the Apnea-Hypopnea Index (AHI) in participants with or without preventive oxygen therapy. Methods: Participants are patients who underwent bariatric surgery without treated OSA and will be will be randomized into arm A or arm B: Arm A: First postoperative night in the hospital with preventive oxygen therapy (standard care), Arm B: First postoperative night in hospital without preventive oxygen therapy (intervention).


Description:

Rationale: The prevalence of obstructive sleep apnea (OSA) in the bariatric surgery population is high and mostly undiagnosed. The best perioperative strategy to manage sleep apnea in bariatric patients remains unclear. A recent study found that monitoring patients with pulsoximetry and giving them preventive oxygen therapy during the first postoperative night is safe and cost effective. In a population with patients with OSA but without obesity, no significant difference in apnea hypopnea index (AHI) was found between patients with and without oxygen therapy during the first postoperative night. The question was raised if preventive oxygen therapy during the first postoperative night after bariatric surgery is needed. Objective: The primary objective of this study is to compare AHI in patients with potentially undiagnosed OSA, treated with or without preventive oxygen therapy, during the first night after bariatric surgery. The secondary objective of this study is to compare sleep architecture in these patients Study design: This is a randomized controlled non-inferiority trial consisting of two arms; Arm A: First postoperative night in the hospital with preventive oxygen therapy (standard care), Arm B: First postoperative night in hospital without preventive oxygen therapy (intervention). Study population: Patients scheduled for primary bariatric surgery without treated OSA Intervention: During the first postoperative night at the hospital patients in intervention arm B will not receive preventive oxygen therapy. Main study parameters/endpoints: Primary endpoint is AHI and secondary endpoints are 30 days complications rate, nursing intervention rate and parameters for sleep architecture and sleep related breathing, score of the Epworth Sleepiness Scale (ESS) and STOP BANG.


Recruitment information / eligibility

Status Recruiting
Enrollment 152
Est. completion date July 2025
Est. primary completion date March 2025
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Undergo primary bariatric surgery (RYGB or SG) - Speak and read the Dutch language Exclusion Criteria: - Revisional bariatric surgery (e.g. sleeve conversion, RYGB after gastric banding) - Same-day discharge after bariatric surgery - Diagnosed OSA with treatment (CPAP, oral appliances) - Professional drivers - Use of alpha blockers - Unable to speak or read the Dutch language

Study Design


Intervention

Other:
No preventive oxygen therapy (2L)
Participants will not receive preventive oxygen 2L during the first postoperative night after bariatric surgery.
Preventive oxygen therapy (2L) standard care
Participants will receive preventive oxygen 2L during the first postoperative night after bariatric surgery, standard care.

Locations

Country Name City State
Netherlands Vitalys Elst

Sponsors (1)

Lead Sponsor Collaborator
Rijnstate Hospital

Country where clinical trial is conducted

Netherlands, 

Outcome

Type Measure Description Time frame Safety issue
Primary Apnea-Hypopnea Index (AHI) AHI will be measured by a home sleep study device (Watchpat300) and will be compared between both arms, the higher the AHI the more severe the sleep apnea First postoperative night
Secondary Complication rate All complication will be scored and will be compared between both arms Until 30 days after surgery
Secondary The number of nursing interventions Nursing interventions will be scored on a form and the number of nursing interventions will be compared between both arms First postoperative night
Secondary Type of nursing interventions e.g. waking up the patient or starting or increasing oxygen therapy/flow, this will be compared between both arms. First postoperative night
Secondary Oxygen Desaturation Index (ODI) ODI will be measured by a home sleep study device (Watchpat300) and will be compared between both arms First postoperative night
Secondary AHI during Rapid Eye Movement (REM) sleep AHI during REM sleep will be measured by a home sleep study device (Watchpat300) and will be compared between both arms First postoperative night
Secondary Respiratory disturbance index (RDI) RDI will be measured by a home sleep study device (Watchpat300) and will be compared between both arms First postoperative night
Secondary Mean saturation Mean saturation will be measured by a home sleep study device (Watchpat300) and will be compared between both arms First postoperative night
Secondary Mean saturation during desaturations, Mean saturation during desaturations will be measured by a home sleep study device (Watchpat300) and will be compared between both arms First postoperative night
Secondary Number of desaturations Number of desaturations will be measured by a home sleep study device (Watchpat300) and will be compared between both arms First postoperative night
Secondary Percentage of saturation <90% will be measured by a home sleep study device (Watchpat300) and will be compared between both arms First postoperative night
Secondary Percentage of saturation <88% will be measured by a home sleep study device (Watchpat300) and will be compared between both arms First postoperative night
Secondary Percentage of saturation <85% will be measured by a home sleep study device (Watchpat300) and will be compared between both arms First postoperative night
Secondary Percentage of saturation <80% will be measured by a home sleep study device (Watchpat300) and will be compared between both arms First postoperative night
Secondary Percentage of saturation <70% will be measured by a home sleep study device (Watchpat300) and will be compared between both arms First postoperative night
Secondary Time (minutes) of saturation <90% will be measured by a home sleep study device (Watchpat300) and will be compared between both arms First postoperative night
Secondary Time (minutes) of saturation <88% will be measured by a home sleep study device (Watchpat300) and will be compared between both arms First postoperative night
Secondary Time (minutes) of saturation <85% will be measured by a home sleep study device (Watchpat300) and will be compared between both arms First postoperative night
Secondary Time (minutes) of saturation <80% will be measured by a home sleep study device (Watchpat300) and will be compared between both arms First postoperative night
Secondary Time (minutes) of saturation <70% will be measured by a home sleep study device (Watchpat300) and will be compared between both arms First postoperative night
Secondary Total sleep time (minutes) Total sleep time will be measured by a home sleep study device (Watchpat300) and will be compared between both arms First postoperative night
Secondary Percentage of REM sleep in total sleep time Percentage of REM sleep will be measured by a home sleep study device (Watchpat300) and will be compared between both arms First postoperative night
Secondary Percentage of Deep sleep in total sleep time Percentage of Deep sleep will be measured by a home sleep study device (Watchpat300) and will be compared between both arms First postoperative night
Secondary Percentage of light sleep in total sleep time Percentage of light sleep will be measured by a home sleep study device (Watchpat300) and will be compared between both arms First postoperative night
Secondary Percentage of awake time Percentage of awake time will be measured by a home sleep study device (Watchpat300) and will be compared between both arms First postoperative night
See also
  Status Clinical Trial Phase
Recruiting NCT04243317 - Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults N/A
Recruiting NCT04101669 - EndoBarrier System Pivotal Trial(Rev E v2) N/A
Terminated NCT03772886 - Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball N/A
Completed NCT03640442 - Modified Ramped Position for Intubation of Obese Females. N/A
Completed NCT04506996 - Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2 N/A
Recruiting NCT06019832 - Analysis of Stem and Non-Stem Tibial Component N/A
Active, not recruiting NCT05891834 - Study of INV-202 in Patients With Obesity and Metabolic Syndrome Phase 2
Active, not recruiting NCT05275959 - Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI) N/A
Recruiting NCT04575194 - Study of the Cardiometabolic Effects of Obesity Pharmacotherapy Phase 4
Completed NCT04513769 - Nutritious Eating With Soul at Rare Variety Cafe N/A
Withdrawn NCT03042897 - Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer N/A
Completed NCT03644524 - Heat Therapy and Cardiometabolic Health in Obese Women N/A
Recruiting NCT05917873 - Metabolic Effects of Four-week Lactate-ketone Ester Supplementation N/A
Active, not recruiting NCT04353258 - Research Intervention to Support Healthy Eating and Exercise N/A
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Recruiting NCT03227575 - Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control N/A
Completed NCT01870947 - Assisted Exercise in Obese Endometrial Cancer Patients N/A
Recruiting NCT05972564 - The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function Phase 1/Phase 2
Recruiting NCT06007404 - Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
Recruiting NCT05371496 - Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction Phase 2